Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2018-07-01
2020-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group A: lumbar plexus block using shamrock technique by 0.3 ml/kg of 0.5% bupivacaine with 1:200000 adrenaline.
Group B: Fascia iliaca block by 0.3 ml/kg of 0.5% bupivacaine with 1:200000 adrenaline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ultrasound guided lumbar plexus block
patients were recieved lumbar plexus block ultrasound guided by shamrock technique using 0.5% bupavacaine in a dose 0.3ml/kg
bupivacaine 0.5% with 1:200000 adrenaline
regional anesthesia to block lumbar plexus for analgesia of lower limb
ultrasound guided Fascia iliaca block
patients were received fascia iliaca block ultrasound guided using 0.5% bupoavacaine in a dose 0.3ml\\kg
bupivacaine 0.5% with 1:200000 adrenaline
regional anesthesia to block lumbar plexus for analgesia of lower limb
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bupivacaine 0.5% with 1:200000 adrenaline
regional anesthesia to block lumbar plexus for analgesia of lower limb
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Local infection.
* Patients with coagulation defects
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menoufia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed hashem
assistant lecturer at menoufia university hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed abd elraof, professor
Role: STUDY_CHAIR
faculty of medicine, anesthesia department
Ezz elden saleh, professor
Role: STUDY_CHAIR
faculty of medicine, anesthesia department
sadek abdelmasih, lecturer
Role: STUDY_DIRECTOR
faculty of medicine, anesthesia department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed hashem
Cairo, Assistant Lecturer, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANET 8/2018
Identifier Type: -
Identifier Source: org_study_id